StudyFinder

BEGIN-OB-19: A Prospective Study to Evaluate Biological and Clinical Effects of Significantly Corrected CFTR Function in Infants and Young Children (BEGIN)

Recruiting

This is a two-part, multi-center, prospective longitudinal, exploratory study of highly effective CFTR modulators and their impact in children with CF on endocrine growth factors, the gut microbiome, respiratory microbiome, liver and pancreatic function, lung function, sweat chloride, and inflammatory markers.

I'm interested

This study is NOT accepting healthy volunteers

Cystic Fibrosis

CF, CFTR Modulator, Cystic Fibrosis, elexacaftor, ivacaftor, tezacaftor, triple combination therapy

Dena Johnson - joh20459@umn.edu
Elissa Downs
NA
STUDY00010861
NCT04509050
See this study on ClinicalTrials.gov

Back